Abstract
The early infant gut microbiota is dominated by bifidobacteria, but there is substantial variation at the (sub)species level. Patterns of postnatal Bifidobacterium subspecies colonization in low or middle-income countries have not been widely studied. We used (sub)species-specific qPCR to quantify B. infantis, B. longum, and B. breve in stool samples from 1132 infants (0-6 months) in urban Dhaka, Bangladesh. B. infantis absolute abundance started low but increased in the first two months, whereas B. longum and B. breve abundances remained comparatively low. B. infantis emerged earlier in infants delivered by C-section, but by ~2 months of age, infants delivered by C-section or vaginally had similar B. infantis abundances. Infant antibiotic exposure, feeding patterns, and maternal stool B. infantis were not associated with infant B. infantis. In settings where B. infantis is widespread, its patterns of postnatal colonization can be used to inform the design of targeted microbiota-modifying interventions in infancy.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://doi.org/10.5683/SP3/WKDQYY
Funding Statement
The study was supported by the Bill and Melinda Gates Foundation (BMGF) under grant INV-007389 to the Hospital for Sick Children and grant GR-02268 to The International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b). The conclusions and opinions expressed in this work are those of the author(s) alone and shall not be attributed to the Foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Research Ethics Board of The Hospital for Sick Children (SickKids) gave ethical approval for this work (no.: 1000063899). Ethical Review Committee of the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) gave ethical approval for this work (no.: PR-19045).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data and code that support the findings of this study are available at the Borealis repository
